Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa

被引:10
作者
Aralaguppe, Shambhu G. [1 ]
Winner, Dane [2 ]
Singh, Kamalendra [3 ]
Sarafianos, Stefan G. [3 ]
Quinones-Mateu, Miguel E. [2 ,4 ]
Soennerborg, Anders [1 ,5 ]
Neogi, Ujjwal [1 ]
机构
[1] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, S-14186 Stockholm, Sweden
[2] Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH USA
[3] Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO USA
[4] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[5] Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
HIV-1 subtype C; East Africa; Gag; virulence; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; RESISTANCE; PROTEASE; VIRUS;
D O I
10.1002/jmv.24610
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: A lower virulence of HIV-1 subtype C (HIV-1C) is suggested to be related to the global dominance of HIV-1C. In this observational study, combining in vivo (clinical monitoring) and in vitro (genotypic, biochemical, and phenotypic assays), we explored whether HIV-1C from East Africa (HIV-1C(EA)) is more pathogenic due to the evolution of a PYxE-insertion (C-PYxEi) in the gag-p6 that also could affect the therapy response. Methods: HIV-1B (n=112) and HIV-1C(EA) (n=128)-infected individuals residing in Sweden were analyzed with regard to Gag-p6 genotype and clinically monitored. Based on the Gag-p6 characteristics, three HIV-1C(EA) and one HIV-1B patient-derived p2-INT-recombinant virus (gag-p2/NCp7/p1/p6/pol-PR/RT/IN) were constructed to analyze viral growth kinetics (VGKs) and drug sensitivity assays. Reverse transcriptase (RT) from the same samples was cloned into the heterodimer expression plasmid (pRT6H-PROT) to analyze catalytic efficiency of RT. Results: A higher viral failure rate and lower pre-therapy CD4(+) T-cell counts were observed in HIV-1C(EA)-infected patients compared to HIV-1B-infected patients. In Gag-p6, PTAP-duplication was more common in HIV-1C. HIV-1C(EA)-infected patients with signature C-PYxEi,C- evidenced very low pre-therapy CD4(+) T-cell counts and suboptimal gain in CD4(+) T-cells following therapy, as compared to the non-C-PYxEi-strains indicating higher virulence. VGKs showed a statistically significant higher replication capacity (RC) for the C-PYxEi viruses than the other two non-C-PYxEi strains. No statistically significant difference was observed in the catalytic efficiency among HIV-1C RTs. Conclusions: This is the first evidence of polymerase independent increased virulence and RC in HIV-1C(EA) following PYxE-insertion that is associated with suboptimal CD4(+) T-cell gain following therapy initiation. J. Med. Virol. 89:106-111, 2017. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 15 条
[1]   CCR5-and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic [J].
Abraha, Awet ;
Nankya, Immaculate L. ;
Gibson, Richard ;
Demers, Korey ;
Tebit, Denis M. ;
Johnston, Elizabeth ;
Katzenstein, David ;
Siddiqui, Asna ;
Herrera, Carolina ;
Fischetti, Lucia ;
Shattock, Robin J. ;
Arts, Eric J. .
JOURNAL OF VIROLOGY, 2009, 83 (11) :5592-5605
[2]   Is HIV-1 evolving to a less virulent form in humans? [J].
Arien, Kevin K. ;
Vanham, Guido ;
Arts, Eric J. .
NATURE REVIEWS MICROBIOLOGY, 2007, 5 (02) :141-151
[3]  
AYEHUNIE S, 1990, LANCET, V336, P942
[4]   Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective [J].
Fraser, Christophe ;
Lythgoe, Katrina ;
Leventhal, Gabriel E. ;
Shirreff, George ;
Hollingsworth, T. Deirdre ;
Alizon, Samuel ;
Bonhoeffer, Sebastian .
SCIENCE, 2014, 343 (6177) :1328-+
[5]   Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden [J].
Haggblom, Amanda ;
Svedhem, Veronica ;
Singh, Kamalendra ;
Sonnerborg, Anders ;
Neogi, Ujjwal .
LANCET HIV, 2016, 3 (04) :E166-E174
[6]   The origin and diversity of the HIV-1 pandemic [J].
Hemelaar, Joris .
TRENDS IN MOLECULAR MEDICINE, 2012, 18 (03) :182-192
[7]   Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial [J].
Kantor, Rami ;
Smeaton, Laura ;
Vardhanabhuti, Saran ;
Hudelson, Sarah E. ;
Wallis, Carol L. ;
Tripathy, Srikanth ;
Morgado, Mariza G. ;
Saravanan, Shanmugham ;
Balakrishnan, Pachamuthu ;
Reitsma, Marissa ;
Hart, Stephen ;
Mellors, John W. ;
Halvas, Elias ;
Grinsztejn, Beatriz ;
Hosseinipour, Mina C. ;
Kumwenda, Johnstone ;
La Rosa, Alberto ;
Lalloo, Umesh G. ;
Lama, Javier R. ;
Rassool, Mohammed ;
Santos, Breno R. ;
Supparatpinyo, Khuanchai ;
Hakim, James ;
Flanigan, Timothy ;
Kumarasamy, Nagalingeswaran ;
Campbell, Thomas B. ;
Eshleman, Susan H. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) :1541-1549
[8]   Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains [J].
Marlowe, N ;
Flys, T ;
Hackett, J ;
Schumaker, M ;
Jackson, JB ;
Eshleman, SH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (10) :1119-1125
[9]   Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain [J].
Martins, Angelica N. ;
Waheed, Abdul A. ;
Ablan, Sherimay D. ;
Huang, Wei ;
Newton, Alicia ;
Petropoulos, Christos J. ;
Brindeiro, Rodrigo D. M. ;
Freed, Eric O. .
JOURNAL OF VIROLOGY, 2016, 90 (02) :768-779
[10]  
Neogi U, 2016, AIDS RES HUM RETROV, V32, P80, DOI [10.1089/AID.2015.0266, 10.1089/aid.2015.0266]